Mejo Chiratteparambil Korah: Development of Vaccines against Gonococcal Disease using the PilVax Platform
Gonorrhoea is a sexually transmitted disease with high prevalence. Due to the emergence of anti-microbial resistance, vaccine development is the top priority to treat gonococcal disease. PilVax is an innovative platform for mucosal vaccination. The aim of this project is to develop nasal gonorrhoea vaccines based on the PilVax platform.
This poster was uploaded for the SGS Research Showcase 2023.